LigaChem Biosciences

TORL BioTherapeutics

This biopharmaceutical company develops antibody-drug conjugates and monoclonal antibodies to treat various cancers for patients with unmet medical needs.

Orum Therapeutics

This biopharmaceutical company develops antibody-degrader conjugates to treat cancer and immune diseases for patients and pharmaceutical partners.

Lytica Therapeutics

This biotechnology company develops peptide-based antibody-drug conjugates to treat oncology and infectious disease patients.

Adcytherix

This biopharmaceutical company develops novel antibody-drug conjugates to treat various forms of cancer for patients with high unmet clinical needs.

LiliumX

This biotechnology company develops a discovery platform and bispecific antibody-drug conjugates for the treatment of cancer and other complex diseases.

Bead Biopharma

This company develops chemical platform technologies to improve the stability and performance of antibody-drug conjugates for pharmaceutical developers and cancer researchers.

Mablink Bioscience

This biotechnology firm develops antibody-drug conjugates for pharmaceutical companies to treat cancer using a proprietary hydrophilic linker platform.

Hummingbird Bioscience

This company develops antibody-based therapeutics and drug conjugates for patients with hard-to-treat cancers and autoimmune diseases.